RSS   Newsletter   Contact   Advertise with us
Post Online Media

Immunocore appoints Paul Fry as chief financial officer

ImmunocoreImmunocore Limited, a biotechnology company, announces the appointment of Paul Fry as chief financial officer.
Mr. Fry joins Immunocore with over 20 years’ experience in senior positions in the life sciences and telecommunications sectors.

Prior to joining Immunocore he served as Director of Global Finance Operations at Vodafone Plc, where he was responsible for key financial controllership activities, core processes as well as large transformation projects and programmes.

Prior to joining Vodafone, Mr. Fry spent more than 25 years at GlaxoSmithKline, serving in a number of roles including Head of Global Finance Services and as CFO for GSK’s Italian Pharmaceutical business.

More recently he oversaw all of the financial aspects of the multibillion dollar transaction which saw GSK divest its oncology business in a transfer for Novartis Vaccines.


 LATEST MOVES FROM United Kingdom 


POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.